8G75
SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound
Summary for 8G75
Entry DOI | 10.2210/pdb8g75/pdb |
EMDB information | 29792 29793 29794 29795 29796 29797 29798 29799 29802 29803 29804 29805 29806 |
Descriptor | Spike glycoprotein, Nanosota-4, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total) |
Functional Keywords | sars-cov-2, viral protein-immune system complex, nanobody, viral protein/immune system |
Biological source | Severe acute respiratory syndrome coronavirus 2 More |
Total number of polymer chains | 6 |
Total formula weight | 469379.18 |
Authors | |
Primary citation | Ye, G.,Pan, R.,Bu, F.,Zheng, J.,Mendoza, A.,Wen, W.,Du, L.,Spiller, B.,Wadzinski, B.E.,Liu, B.,Perlman, S.,Li, F. Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. J.Virol., 97:e0144823-e0144823, 2023 Cited by PubMed: 37855638DOI: 10.1128/jvi.01448-23 PDB entries with the same primary citation |
Experimental method |
Structure validation
Download full validation report